Europe Anti-snoring Device Market – Consumer Trends & Forecast 2026–2034

Europe Anti-snoring Device Market Size and Forecast 2026-2034

Europe Anti-snoring Device Market is expected to reach US$ 987.03 Million by 2034 from US$ 520.89 Million in 2025, with a CAGR of 7.36% from 2026 to 2034. The Europe anti-snoring device market is growing due to rising awareness of sleep disorders, increasing prevalence of obstructive sleep apnea, growing adoption of non-invasive treatment options, technological advancements in oral appliances and wearables, and expanding access to sleep healthcare services.

Europe Anti-snoring Device Industry Overview

Anti-snoring devices are products designed to reduce or eliminate snoring by improving airflow through the upper airway during sleep. These devices include mandibular advancement devices (MADs), tongue-stabilizing devices, nasal dilators, chin straps, positional therapy devices, and smart wearable solutions. They are commonly used by individuals suffering from primary snoring and mild-to-moderate obstructive sleep apnea (OSA). Anti-snoring devices offer a non-invasive alternative to surgical procedures and continuous positive airway pressure (CPAP) therapy. Increasing awareness regarding the health risks associated with untreated snoring, coupled with technological advancements and growing demand for home-based sleep solutions, is driving market adoption across Europe.

The Europe anti-snoring device market is experiencing steady growth due to the increasing prevalence of sleep-disordered breathing conditions and rising awareness regarding sleep health. A growing elderly population, increasing obesity rates, and higher diagnosis rates of obstructive sleep apnea are expanding the target patient population. Consumers are increasingly seeking comfortable, non-invasive alternatives to CPAP therapy, driving demand for oral appliances, positional therapy devices, and smart sleep technologies. Additionally, advancements in digital dentistry, 3D printing, wearable sensors, and customized oral devices are enhancing treatment effectiveness and patient compliance. Expanding telehealth services and improved access to sleep disorder management are further supporting market growth across Europe.

Recent Developments in Europe Anti-snoring Device Market

• Following FDA 510(k) clearance, SnoreLessNow introduced the Anti Snore Mouth Guard+, marketed in Europe as SomnoFit-S®. The mandibular advancement device is designed to gently reposition the lower jaw forward during sleep, helping to maintain an open airway and reduce snoring. The product provides a comfortable, non-invasive alternative to CPAP therapy for individuals seeking effective snoring management without the use of masks or powered equipment.

Growth Drivers for the Europe Anti-snoring Device Market

Increasing Demand for Comfortable and Customizable Oral Appliances

The growing preference for comfortable and personalized anti-snoring solutions is a major driver of the European market. Traditional snoring treatments often suffer from low patient compliance due to discomfort and inconvenience. As a result, manufacturers are increasingly focusing on customized oral appliances that provide improved fit, comfort, and effectiveness. Digital dentistry and advanced manufacturing technologies are enabling the production of highly individualized devices that can be tailored to patient-specific anatomical requirements. These innovations improve treatment adherence and clinical outcomes while supporting broader adoption among individuals seeking non-invasive snoring management options. Growing consumer awareness of sleep quality and the availability of direct-to-consumer solutions are also contributing to increased demand across Europe.

In December 2024, ZQuiet introduced the ZQuiet Advance Anti-Snoring Mouthpiece, featuring an adjustable custom-fit design and enhanced comfort-focused engineering to improve snoring relief and user compliance.

Advancements in Digital and 3D-Printed Sleep Therapy Devices

Technological innovation is transforming the anti-snoring device market through the introduction of digitally designed and 3D-printed treatment solutions. Advanced manufacturing techniques improve precision, customization, and patient comfort while reducing production time. These innovations enable healthcare providers to deliver more effective oral appliances with enhanced durability and fit. The adoption of digital workflows in dentistry and sleep medicine is also supporting wider use of customized snoring management devices. As patients increasingly seek discreet and convenient treatment options, manufacturers are investing in next-generation products that combine advanced materials with digital design capabilities. This trend is expected to accelerate market growth throughout Europe.

In May 2024, Glidewell launched the Digital Silent Nite® 3D Sleep Appliance, a fully digital, 3D-printed mandibular advancement device developed to alleviate snoring and mild-to-moderate obstructive sleep apnea.

Growing Adoption of Innovative Sleep Apnea and Snoring Therapies

The increasing need for alternatives to CPAP therapy is driving demand for innovative anti-snoring and sleep apnea treatments. Patients are seeking solutions that offer greater comfort, mobility, and long-term adherence. Manufacturers are responding by introducing advanced oral appliances, neuromodulation systems, and integrated sleep technologies that address both snoring and obstructive sleep apnea. Rising diagnosis rates and growing investments in sleep medicine are supporting the adoption of these solutions across Europe. As healthcare providers focus on improving patient outcomes through personalized therapies, the market is witnessing increased demand for innovative treatment options.

In December 2024, Nyxoah announced the commercial launch of its Genio® therapy in England, providing patients with an innovative neurostimulation-based treatment option for obstructive sleep apnea and related snoring conditions.

Challenges in the Europe Anti-snoring Device Market

Limited Consumer Awareness and Underdiagnosis

A major challenge facing the European anti-snoring device market is the underdiagnosis of sleep-related breathing disorders. Many individuals consider snoring a lifestyle issue rather than a medical condition, delaying diagnosis and treatment. Consequently, a significant proportion of potential users remain unaware of available treatment options. Additionally, access to sleep studies and specialist consultations varies across European countries, leading to differences in diagnosis rates. Limited public understanding of the relationship between chronic snoring and obstructive sleep apnea further restricts market penetration. Improving education regarding sleep health and expanding screening initiatives will be important for increasing adoption of anti-snoring devices across the region.

Product Compliance and Comfort Concerns

Although anti-snoring devices offer non-invasive treatment options, maintaining long-term patient compliance remains challenging. Some users experience discomfort, jaw soreness, nasal irritation, or difficulty adapting to oral appliances and positional therapy devices. These issues may reduce treatment adherence and lead patients to discontinue use. Individual anatomical differences can also influence device effectiveness, creating variability in treatment outcomes. Furthermore, consumers may be hesitant to invest in premium products without clear evidence of long-term benefits. Manufacturers must continue improving device design, customization, and comfort while providing clinical evidence supporting effectiveness to encourage sustained usage and strengthen market acceptance.

France Anti-snoring Device Market

France is a significant market for anti-snoring devices due to growing awareness of sleep apnea, rising obesity rates, and increasing utilization of sleep diagnostic services. Demand is particularly strong for oral appliances and neurostimulation therapies that offer alternatives to CPAP treatment. The country's well-established healthcare system and growing focus on sleep health are supporting adoption of innovative snoring management solutions.

In July 2024, Inspire Medical Systems announced the nationwide reimbursement and commercialization expansion of Inspire® Therapy in France. The implantable hypoglossal nerve stimulation device is designed for patients with moderate-to-severe obstructive sleep apnea who are unable to tolerate CPAP therapy. The reimbursement approval significantly expanded patient access to the therapy across France.

Germany Anti-snoring Device Market

Germany remains the largest anti-snoring device market in Europe, supported by a strong sleep medicine infrastructure, widespread diagnosis of sleep disorders, and high adoption of advanced treatment technologies. The country has numerous accredited sleep laboratories and specialized clinics that facilitate the use of oral appliances and innovative sleep therapies. Growing awareness of the health risks associated with untreated snoring continues to drive demand.

In October 2025, Smartee launched the Smartee Sleep Aligner, the world's first clear aligner designed to address primary snoring and obstructive sleep apnea while simultaneously providing orthodontic correction. The product offers a discreet and patient-friendly treatment option that aligns with Germany's growing demand for innovative oral sleep therapies.

Italy Anti-snoring Device Market

Italy's anti-snoring device market is expanding due to increasing awareness of sleep health, rising prevalence of obesity-related sleep disorders, and growing acceptance of non-invasive treatment options. Oral appliance therapy is gaining traction among patients seeking alternatives to CPAP treatment. Technological advancements in customized dental sleep devices are also supporting market development.

In July 2025, Vivos Therapeutics received expanded commercialization support for its VidaSleep™ Oral Appliance, a patented device developed for the treatment of snoring and mild-to-moderate obstructive sleep apnea. The appliance utilizes the company's proprietary technology to improve airway function and supports the growing adoption of oral appliance therapy across European markets, including Italy.

Spain Anti-snoring Device Market

Spain is experiencing increasing demand for anti-snoring devices due to rising awareness of sleep-disordered breathing, growing healthcare expenditure, and increasing adoption of home-based sleep solutions. Consumers are showing greater interest in convenient and non-invasive technologies that improve sleep quality and reduce snoring. Expanding sleep clinic networks are also supporting market growth.

In November 2025, Quiet Lab announced the launch of the Quiet Lab Mouthpiece, a scientifically engineered anti-snoring oral device developed to improve nighttime airflow and reduce snoring. The product incorporates advanced dental biomechanics and respiratory science principles to provide a comfortable, non-powered solution for snoring management. The launch strengthens the availability of innovative oral anti-snoring devices in European markets, including Spain.

Europe Oral Anti-Snoring Appliances Market

The Europe Oral Anti-Snoring Appliances market is experiencing steady growth due to increasing awareness of sleep-disordered breathing and the rising preference for non-invasive treatment options. Oral appliances, particularly mandibular advancement devices (MADs) and tongue-retaining devices, are widely used to reduce snoring by maintaining an open airway during sleep. These devices are gaining popularity among patients with primary snoring and mild-to-moderate obstructive sleep apnea who seek alternatives to continuous positive airway pressure (CPAP) therapy. Advances in digital dentistry, 3D scanning, and customized appliance manufacturing have improved comfort, fit, and treatment effectiveness. Additionally, increasing involvement of dentists in sleep medicine and growing acceptance of oral appliance therapy are supporting market expansion across Europe throughout the forecast period.

Europe Anti-Snoring Devices Retail Pharmacies Market

The Europe Anti-Snoring Devices Retail Pharmacies market represents an important distribution channel, driven by the accessibility and convenience offered by retail pharmacy networks. Consumers frequently purchase over-the-counter anti-snoring products such as nasal dilators, nasal strips, chin straps, and entry-level oral appliances through pharmacy outlets. Retail pharmacies provide consumers with easy access to snoring management solutions without requiring specialist consultations, making them a preferred purchasing channel for mild snoring cases. Growing consumer awareness of sleep health and increasing demand for self-care products are supporting sales through pharmacy chains across Europe. Furthermore, pharmacists play a valuable role in educating consumers about available treatment options and guiding product selection, contributing to the continued growth of this market segment.

Europe Homecare Anti-Snoring Devices Market

The Europe Homecare Anti-Snoring Devices market is growing rapidly as consumers increasingly seek convenient and cost-effective solutions for managing snoring and mild sleep-disordered breathing conditions at home. Homecare devices include oral appliances, nasal dilators, positional therapy products, chin straps, wearable sleep monitors, and other non-invasive solutions designed for independent use. Rising awareness regarding the impact of poor sleep quality on overall health is encouraging consumers to adopt home-based treatment options. The expansion of e-commerce platforms and direct-to-consumer sales channels has further improved product accessibility across Europe. In addition, technological advancements in smart sleep devices and connected monitoring systems are enhancing user experience and treatment effectiveness. These factors continue to support strong growth within the European homecare anti-snoring devices market.

Market Segmentations

Product

• Oral Appliances
• Nasal Devices
• Tongue-Stabilizing Devices
• Chin Straps
• Position Control Devices
• Expiratory Positive Airway Pressure (EPAP) Therapy Devices  

Distribution Channel

• Retail Pharmacies
• Online Stores

End User

• Homecare
• Others

Countries

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Russia
• Poland
• Greece
• Norway
• Romania
• Portugal
• Rest of Europe

All the Key players have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Koninklijke Philips N.V.
• ResMed, Inc.
• SomnoMed Limited
• GSK Plc.
• Apnea Sciences Corporation
• ZQuiet (Sleeping Well, LLC)
• Airway Management, Inc.
• Fisher & Paykel Healthcare Limited.
• Tomed GmbH

Report Details: